Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mediwelcome Healthcare Management & Technology Inc. ( (HK:2159) ) has shared an update.
Mediwelcome Healthcare Management & Technology Inc. has warned investors that, while it still expects to post a loss for the year ended 31 December 2025, the deficit should narrow significantly compared with 2024. The improvement is attributed to stronger performance in its core business and a strategic pivot toward higher-margin projects, which has lifted gross profit.
The company stressed that these figures are based on preliminary, unaudited management accounts and remain subject to further review and potential adjustment. Investors are urged to act cautiously until the final annual results, expected in late March 2026, confirm whether the group can fully return to profitability or will remain in a reduced loss position.
The most recent analyst rating on (HK:2159) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Mediwelcome Healthcare Management & Technology Inc. stock, see the HK:2159 Stock Forecast page.
More about Mediwelcome Healthcare Management & Technology Inc.
Mediwelcome Healthcare Management & Technology Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare management and technology sector. The group focuses on core principal healthcare-related services and has recently emphasized higher-margin projects to improve its overall profitability and gross profit profile.
Average Trading Volume: 374,863
Technical Sentiment Signal: Buy
Current Market Cap: HK$490M
Find detailed analytics on 2159 stock on TipRanks’ Stock Analysis page.